Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Oral Oncol. 2018 Oct 11;86:278–287. doi: 10.1016/j.oraloncology.2018.10.005

Table 1:

Demographic data of oropharyngeal HNSCC patients enrolled in the study

Parameter HNSCC Cohort (n=74)
Gender Male = 58; Female = 16
Race Caucasian = 69; African American = 5
Smoking History Yes = 46; No = 16
Alcohol History Yes = 44; No = 17
Tumor Grade Poor = 14; Moderate/Well = 26
Perineural Invasion No = 39; Yes = 13
Radiation Therapy No = 15; Yes = 57
Chemotherapy No = 33; Yes = 39
HPV Status No = 25; Yes = 48
Most recent Cancer Status No Evidence of Disease = 49; Recurrence = 22
Overall Survival Dead = 38; Alive = 36
Pathologic T Stage Unknown = 8
T1 = 27
T2 = 28
T3 = 9
T4 = 2
Pathologic N Stage Unknown = 13
N0 = 8
Any N = 53